Mengying Yao

机构：Army Medical University, Xinqiao Hospital, First Affiliated Hospital of Zhengzhou University · ORCID：0009-0002-2623-4342

发表论文 17 篇 · 总被引 279 次 · h-index 9

代表论文

• The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease (2022 · Frontiers in Pharmacology · 被引 98)
• REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells (2023 · JCI Insight · 被引 42)
• Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy (2023 · Kidney International · 被引 34)
• Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis (2022 · Frontiers in Pharmacology · 被引 24)
• Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study (2024 · Biomedicine & Pharmacotherapy · 被引 18)
• Isoliensinine Attenuates Renal Fibrosis and Inhibits TGF-β1/Smad2/3 Signaling Pathway in Spontaneously Hypertensive Rats (2023 · Drug Design Development and Therapy · 被引 18)